Niranjan Kanesa-thasan, Chief Medical Officer at Icosavax, Inc. (ICVX), sold 1,794 shares at $10.69 ($19K) on 2023-02-13, disclosed to the SEC on 2023-02-15.
Scheduled sale ($19k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ICVX | SELL | 2023-08-01 | $29K | — | Filing → |
| ICVX | SELL | 2022-08-02 | $22K | — | Filing → |
| ICVX | BUY | 2021-08-02 | $100K | — | Filing → |